Stockreport

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

Cytek Biosciences, Inc.  (CTKB) 
PDF FREMONT, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced preliminary, unau [Read more]